Tg(Myh6-AIP/PLN*)46Jded
Transgene Detail
|
Symbol: |
Tg(Myh6-AIP/PLN*)46Jded |
Name: |
transgene insertion 46, John R Dedman |
MGI ID: |
MGI:3836606 |
Synonyms: |
alpha-MHC-AIP4-SR, SR-AIP |
Transgene: |
Tg(Myh6-AIP/PLN*)46Jded Location: unknown
|
Alliance: |
Tg(Myh6-AIP/PLN*)46Jded page
|
|
Tg(Myh6-AIP/PLN*)46Jded/0 females producing at least 3 litters develop cardiac hypertrophy and dilated heart failure
Show the 1 phenotype image(s) involving this allele.
|
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Myh6-AIP/PLN*)46Jded expresses
2 genes
|
|
|
Mutation details: The alpha-MHC-AIP4-SR transgene was designed with the 5.5-kb murine alpha-myosin heavy chain (alpha-MHC or Myh6) promoter, an AIP4 CaMKII inhibitor domain (encoding a tetramer of the CaMKII autocamtide inhibitory peptide AIP (KKALRRQEAVDAL; a 13-amino acid sequence known to be a highly specific and potent inhibitor of CaMKII)), a FLAG epitope (DYKDDDDK), and a synthetic truncated phospholamban (PLB) transmembrane domain (amino acids 23-52 with L31A/N34A mutations to ensure AIP4 is targeted to the sarcoplasmic reticulum (SR) without the usual inhibition of the PLB transmembrane domain on SERCA activity). This transgene was injected into pronuclei of FVB/N fertilized mouse oocytes, and transgenic offspring were bred to FVB/N to establish founder line 46 (found to carry an estimated 2 copies of the transgene).
(J:84333)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:84333 Ji Y, et al., Targeted inhibition of Ca2+/calmodulin-dependent protein kinase II in cardiac longitudinal sarcoplasmic reticulum results in decreased phospholamban phosphorylation at threonine 17. J Biol Chem. 2003 Jul 4;278(27):25063-71 |
All: |
3 reference(s) |
|